Mammograms are effective methods of screening and diagnosing the disease even before symptoms arise, but it is still important to be aware of the signs and symptoms that may indicate cancer.
Profiling the biologic make-up of breast cancer tissue can help doctors determine how well a patient will respond to different cancer treatments and how aggressive the cancer might be.
Scientists are making headway in understanding the basic biological mechanisms at work in inflammatory breast cancer (IBC)—and how to intervene in ways that may slow or stop the cancer.
When someone is diagnosed with breast cancer, doctors determine the stage of the disease – which indicates how much cancer is in the body, whether it has spread beyond the breast, and, if so, how extensively.
Women who develop breast cancer when they're relatively young – under age 45 – face a variety of issues unique to their stage of life.
Every year in the United States, one in 3,000 women will be diagnosed with breast cancer during pregnancy.
"Overall, contraceptives still have a favorable risk benefit for women as contraception," says Wendy Chen, MD, a senior physician in Dana-Farber's Susan F. Smith Center for Women's Cancers.
Each time the metastatic breast cancer spreads too deeply into Sayde Patel’s lungs, she changes clinical trials. And after six switches in 10 years, she maintains a glass-half-full attitude about the process.
Love and commitment have enabled Lynda and Ellen Thomas to get through Lynda’s diagnosis and treatment for inflammatory breast cancer (IBC).
So far, CDK4/6 inhibitors have been shown to be most effective in treating advanced estrogen-receptor positive, HER2-negative breast cancer.
Many factors contribute to increased breast cancer risk for some women — including certain inherited genes. About 5 to 10 percent of breast cancer cases are thought to be hereditary, meaning that they are the direct result of gene mutations passed on from a parent. Genes are individual units of […]
By Patrick Martin I’ll never forget our first appointment at Dana-Farber — less than 24 hours after my wife, Meghan, heard the harsh news that she had stage IV breast cancer. I can remember the shoes I wore, because I was staring down at them in the waiting room. I […]
Is there a link between soy and an increased risk of breast cancer? “That’s one of the most common questions I get from breast cancer survivors,” says Wendy Chen, MD, MPH, a breast oncologist with the Susan F. Smith Center for Women’s Cancers at Dana-Farber. While laboratory studies on soy […]
In early 2015, Kim Delling had put her 2009 bout with breast cancer behind her. Then, at a routine checkup, her doctor ordered an additional test. “I knew something was up,” recalls Delling, a 50-year-old real estate agent in Wilmington, Mass. The cancer had come back. It had spread to her lungs, […]
Immunotherapy refers to treatments that use the body’s own immune system to combat diseases. While no immunotherapy drugs are currently approved for breast cancer, clinical trials at Dana-Farber and elsewhere are exploring the effectiveness of these drugs — and whether they could work in combination with other cancer therapies. “I […]
When breast cancer spreads beyond the breast to other parts of the body, such as the bones, brain, and/or other organs, it is called metastatic breast cancer. Depending on their location, metastatic cancer growths can cause pain and neurologic symptoms such as numbness and weakness. Patients with metastatic breast cancer, […]
By Brittany Collins “Men don’t get breast cancer,” a practitioner told my father, who had concerning symptoms and a sister who carries a BRCA-2 mutation. “You shouldn’t worry.” This was how my family’s cancer journey began. Years prior, my paternal grandmother passed away from the disease, and my aunt had […]
When breast cancer spreads to other parts of the body, such as the bones, brain, liver, or lungs, it is called metastatic (also referred to as advanced or stage IV). While it is not curable, metastatic breast cancer can be treatable — especially with the advent of new therapies, including biologic targeted […]
When I was young, I wanted to be a doctor. I was the kid who would cry with my friends when they skinned their knees, and do whatever I could to comfort them. In college I learned there were other jobs in healthcare where I could help people, and I […]
“The jig is up.” At least, that’s what Christine Ernst thought as she waited for the mammogram technician to deliver the bad news that she knew was coming. What Ernst didn’t know was what exactly that bad news would be, but eventually it became clear: she had stage II HER2-positive […]